Wordt geladen...
Dabigatran: A new oral anticoagulant. Guidelines to follow in oral surgery procedures. A systematic review of the literature
BACKGROUND: Dabigatran is a newly commercialized drug that is replacing other anticoagulants in the prevention of venous thromboembolism, stroke and systemic arterial valve embolism. It acts directly on thrombin presenting in a dynamic and predictable way, which does not require monitoring these pat...
Bewaard in:
| Gepubliceerd in: | Med Oral Patol Oral Cir Bucal |
|---|---|
| Hoofdauteurs: | , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Medicina Oral S.L.
2016
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5116109/ https://ncbi.nlm.nih.gov/pubmed/27694780 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4317/medoral.21202 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|